Article
Outcomes in Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients
17 Jul 2024
Abstract excerpt
Abstract Rationale Allogeneic hematopoietic stem-cell transplantation (Allo-HSCT) recipients are still believed to be poor candidates for ICU management. Methods We investigated outcomes and determinants of mortality in a large multicenter retrospective cohort of Allo-HSCT patients admitted between January 1, 2015, and December 31, 2020, to 14 French ICUs. The primary endpoint was 90-day mortality. Measurements...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
